4-(4-吡啶甲基）苯胺 | 27692-74-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(4-吡啶甲基）苯胺
• 英文名称: 4-(4-aminobenzyl)pyridine
• 英文别名: 4-(4-pyridinylmethyl)benzenamine；4-(4-pyridylmethyl)aniline；4-(pyridin-4-ylmethyl)aniline
• CAS: 27692-74-6
• 化学式: C₁₂H₁₂N₂
• mdl: MFCD00053060
• 分子量: 184.241
• InChiKey: WZXYYQHVDJMIFF-UHFFFAOYSA-N

物化性质

• 熔点：
  152-153 °C
• 沸点：
  354.0±22.0 °C(Predicted)
• 密度：
  1.121±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.083
• 拓扑面积：
  38.9
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xn
• 危险类别码：
  R20/21/22
• 海关编码：
  2933399090
• 安全说明：
  S26,S36/37/39
• WGK Germany：
  3
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  应存于室温、避光且在惰性气体保护下。

SDS

Name:	4-(4-Pyridylmethyl)aniline tech Material Safety Data Sheet
Synonym:
CAS:	27692-74-6

Section 1 - Chemical Product MSDS Name:4-(4-Pyridylmethyl)aniline tech Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
27692-74-6	4-(4-Pyridylmethyl)aniline		unlisted

Hazard Symbols: XN
Risk Phrases: 22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed. Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 27692-74-6: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H12N2
Molecular Weight: 184.24

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Not available.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 27692-74-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-(4-Pyridylmethyl)aniline - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 27692-74-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 27692-74-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 27692-74-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(4-吡啶甲基）苯胺 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 N-甲基乙酰胺 、 乙醚 、 二氯甲烷 、 水 为溶剂， 生成 2-Bromo-4-(pyridin-4-ylmethyl)aniline
  参考文献：
  名称：

  Substituted biphenyl compounds

  摘要：

  化合物的化学式(I)：##STR1## 其中：R.sub.1代表未取代或取代的环烷基，苯基，萘基，杂环基，烷基或烯基，A代表键，氧，硫，群组##STR2##，群组##STR3##或群组##STR4##其中Rc代表氢，烷基或环烷基，R.sub.2代表卤素，取代或未取代的烷基，取代或未取代的烯基，取代或未取代的炔基，环烷基，甲酰，羧基，烷基羰基，环烷基羰基，烷氧羰基，环烷氧羰基，可选取代的氨基甲酰胺，可选取代的氨基，甲酰氨基，氰基，可选取代的氨基甲酰胺基，羟基氨甲基，酰胺肟，肼酮或从以下选择的群组：##STR5##其中R.sub.21，R.sub.22和R.sub.23如说明书中所定义，R.sub.3代表氢或烷基，环烷基或酰基，或##STR6##一起形成环##STR7##X为氧，硫或NR"，B为苯基，Ra和Rb，可以相同或不同，每个代表氢，卤素，或烷基，羟基，烷氧基，羧基，多卤代烷基，氰基，硝基，烷氧羰基，环烷氧羰基，氨基，氨基甲酰胺基，磺酰，烷基磺酰，环烷基磺酰或氨基磺酰，它们的异构体以及与药学上可接受的酸或碱形成的加合物，以及含有它们的药物制剂，用作PDE IV抑制剂。

  公开号：

  US05877190A1
• 作为产物：
  描述：

  4-苄基吡啶 在 盐酸 、 tin 作用下， 生成 4-(4-吡啶甲基）苯胺
  参考文献：
  名称：

  Tschitschibabin; Kuindshi; Benewolenskaja, Chemische Berichte, 1925, vol. 58, p. 1585

  摘要：

  DOI：

文献信息

• 1H-Indole-2,3-dione derivatives
  申请人：——

  公开号：US04322533A1

  公开（公告）日：1982-03-30

  1-R.sub.1 -4- or 5-[4-pyridinyl-(CH.sub.2).sub.n ]-1H-indole-2,3-dione 3-Q derivatives, useful as cardiotonics, bronchodilators, anti-asthmatics, anti-allergics and anti-cholinergics, are prepared by cyclization of N-3- or 4-[4-pyridinyl-(CH.sub.2).sub.n ]phenyl}glyoxalamide oxime with acid; reaction of the product thus obtained with a carbonyl reactive reagent to prepare a compound where Q is other than O; and reaction of a compound where Q is either O or other than O with a lower-alkyl, hydroxy-lower-alkyl or di-lower-alkylamino-lower-alkyl ester of a strong mineral acid or with a carbo-lower-alkoxy-lower-alkyl halide to prepare compounds where R.sub.1 is other than hydrogen.

  1-R.sub.1 -4-或5-[4-吡啶基-(CH.sub.n).sub.n ]-1H-吲哚-2,3-二酮3-Q衍生物，可用作心力衰竭药、支气管扩张剂、抗哮喘药、抗过敏药和抗胆碱药，通过将N-3-或4-[4-吡啶基-(CH.sub.2).sub.n ]苯基}甘二酰胺肟环化与酸反应制备；将所得产物与羰基反应试剂反应以制备Q不为O的化合物；将Q为O或非O的化合物与强矿酸的低烷基、羟基-低烷基或二-低烷氨基-低烷基酯或羧基-低烷氧基-低烷基卤代烷反应以制备R.sub.1不为氢的化合物。
• Cobalt nanoclusters coated with N-doped carbon for chemoselective nitroarene hydrogenation and tandem reactions in water
  作者：Silvia Gutiérrez-Tarriño、Sergio Rojas-Buzo、Christian W. Lopes、Giovanni Agostini、Jose. J. Calvino、Avelino Corma、Pascual Oña-Burgos

  DOI：10.1039/d1gc00706h

  日期：——

  selective non-noble metal-based catalysts for the chemoselective reduction of nitro compounds in aquo media under mild conditions is an attractive research area. Herein, the synthesis of subnanometric and stable cobalt nanoclusters, covered by N-doped carbon layers as core–shell (Co@NC-800), for the chemoselective reduction of nitroarenes is reported. The Co@NC-800 catalyst was prepared by the pyrolysis

  用于在温和条件下化学选择性还原水介质中硝基化合物的活性和选择性非贵金属基催化剂的开发是一个有吸引力的研究领域。在此，报道了合成亚纳米和稳定的钴纳米团簇，由 N 掺杂的碳层作为核 - 壳层（Co@NC-800）覆盖，用于硝基芳烃的化学选择性还原。所述钴@ NC-800催化剂是由钴（TPY）的热解制备的2复合浸渍在 Vulcan 碳上。事实上，基于六个 N-Co 键的分子复合物的使用推动了由 N 掺杂碳层覆盖的明确和分布的钴核-壳纳米簇的形成。为了阐明它的性质，它已经通过使用几种先进的技术来充分表征。此外，这种制备的催化剂在温和的反应条件下对用H 2还原硝基化合物显示出高活性、化学选择性和稳定性。水被用作绿色溶剂，改善了之前基于钴催化剂的结果。此外，Co@NC-800通过硝基芳烃的还原胺化，该催化剂对于一锅合成仲芳基胺和异吲哚啉酮也具有活性和选择性。最后，基于衍射和光谱研究，已提出具有表面 Co​​N
• Microwave‐assisted reduction of aromatic nitro compounds with novel oxo‐rhenium complexes
  作者：Gabriele Grieco、Olivier Blacque

  DOI：10.1002/aoc.6452

  日期：2022.1

  The reduction of several aromatic nitro compounds to amines by means of the two novel catalytic systems ([IMes]2ReOBr3)/PhSiH3 and ([Py]3ReNOBr2)/PhSiH3 under microwave irradiation is here reported. These two systems were able to perform the reduction of nitro groups with higher TON and TOF when compared with previously reported systems based on oxo-rhenium core under standard heating, although they

  本文报道了在微波辐照下通过两种新型催化体系([IMes] 2 ReOBr 3 )/PhSiH 3和([Py] 3 ReNOBr 2 )/PhSiH 3将几种芳族硝基化合物还原为胺。与先前报道的基于氧铼核的系统在标准加热下相比，这两个系统能够以更高的 TON 和 TOF 还原硝基，尽管与已知系统相比，它们的反应范围较窄。
• Commercially Available CuO Catalyzed Hydrogenation of Nitroarenes Using Ammonia Borane as a Hydrogen Source
  作者：Jialei Du、Jie Chen、Hehuan Xia、Yiwei Zhao、Fang Wang、Hong Liu、Weijia Zhou、Bin Wang

  DOI：10.1002/cctc.201902391

  日期：2020.5.7

  dehydrogenation and nitroarenes hydrogenation has been reported as a novel strategy for the preparation of aromatic amines. However, the practical application of this strategy is subjected to the high‐cost and tedious preparation of supported noble metal nanocatalysts. The commercially available CuO powder is herein demonstrated to be a robust catalyst for hydrogenation of nitroarenes using ammonia borane

  串联氨硼烷脱氢和硝基芳烃氢化已被报道为制备芳族胺的新策略。然而，该策略的实际应用受到昂贵且繁琐的负载型贵金属纳米催化剂的制备的影响。本文证明可商购获得的CuO粉末是在温和条件下使用氨硼烷作为氢源用于硝基芳烃加氢的强力催化剂。通过这种方法可以获得许多胺（甚至是位阻，卤代和二胺）。这种单金属催化剂的特点是无载体，出色的化学选择性，低成本和高可回收性，这将有利于其在制备还原化学中的未来应用。
• Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
  申请人：Mutahi W. Mwangi

  公开号：US20070167435A1

  公开（公告）日：2007-07-19

  Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein: M is CH or N; U and W are each CH, or one of U and W is CH and the other is N; X is a bond, alkylene, —C(O)—, —C(N—OR 5 )—, —C(N—OR 5 )—CH(R 6 )—, —CH(R 6 )—C(N—OR 5 )—, —O—, —OCH 2 —, —CH 2 O— or —S(O) 0-2 —; Y is —O—, —(CH 2 ) 2 —, —C(═O)—, —C(═NOR 7 )— or —SO 0-2 —; Z is a bond, optionally substituted alkylene or alkylene interrupted by a heteroatom or heterocyclic group; R 1 is optionally substituted alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heterocycloalkyl, or benzimidazolyl or a derivative thereof; R 2 is optionally substituted alkyl, alkenyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, cycloalkyl or heterocycloalkyl; and the remaining variables are as defined in the specification; compositions and methods for treating an allergy-induced airway response, congestion, diabetes, obesity, an obesity-related disorder, metabolic syndrome and a cognition deficit disorder using said compounds, alone or in combination with other agents.

  揭示了以下化合物的结构式或其药学上可接受的盐或溶剂，其中：M为CH或N；U和W分别为CH，或者U和W中的一个为CH，另一个为N；X为键，烷基，—C(O)—，—C(N—OR5)—，—C(N—OR5)—CH(R6)—，—CH(R6)—C(N—OR5)—，—O—，—O —，—CH2O—或—S(O)0-2—；Y为—O—，—(CH2)2—，—C(═O)—，—C(═NOR7)—或—SO0-2—；Z为键，可选择地取代的烷基或被杂原子或杂环基中断的烷基；R1为可选择地取代的烷基，环烷基，芳基，芳基烷基，杂芳基，杂环烷基或苯并咪唑基或其衍生物；R2为可选择地取代的烷基，烯基，芳基，芳基烷基，杂芳基，杂芳基烷基，环烷基或杂环烷基；其余变量如规范中所定义；使用这些化合物，单独或与其他药剂联合使用，治疗由过敏引起的气道反应、充血、糖尿病、肥胖症、与肥胖有关的疾病、代谢综合征和认知缺陷障碍的组合物和方法。